Home > Medical affairs


 

Takeda online training As a Medical Affairs Manager, your role traverses a wide spectrum of areas from selecting which pre-clinical candidates to pursue into clinical trials and developing optimized clinical trial strategies, through to dealing with KOLs, running investigator meetings, and preparing your company and relevant documentation for the regulatory authorities.

The PHASE II International team has built an enviable reputation for assisting clients achieve in all of these areas.

From optimizing a product's target profile to developing a new product's clinical trial strategy through to medical education, training, publication planning and medical writing, PHASE II can help.

Browse this section to see how PHASE II can assist you across your workload including:

Clinical trial strategy optimization: planning, executing and managing phase I-IV clinical trials, including target product profile optimization, formulating development plans, evaluation of data from proof of concept and pivotal trials.
Regulatory writing support: clinical assessments, risk benefit analysis, compiling clinical dossiers and databases, assessing dossiers for NDA/ EMEA submission, writing expert reports for NDA/ EMEA registration, writing overviews of efficacy and safety, compiling regulatory responses for NDA/ EMEA
Participating in end of phase II meetings with regulatory authorities
Development of therapeutic area training materials and workshop organization
Medico-marketing strategies: value demonstration and health economics, quality of life, differentiation from competitors, publication and presentation planning and execution, review and editorial comment on manuscripts, posters, approval of copy for medico-marketing purposes.


Pre-clinical candidate selection
Target product profile (TPP) optimization
Clinical trial strategy
Regulatory documentation
Investigator meetings

Key opinion leaders
Pre-marketing project plan
Strategic publication planning
Congress
Pharmacoeconomic

Medical education
Public relations
Patient advocacy communication
Market access
Online communications
Training


Adoption

Lifecycle


Takeda online training

Abbott Leuprorelin HE















"We are entering a new market with ramelteon - and the KOL and marketing intelligence study conducted by PHASE II International has provided us with invaluable insights about who's who in sleep disorders and what current perceptions exist in the insomnia market. We'll be using this information to make informed decisions as we plan our pre-marketing for this exciting product in the UK. Great work, great service from an exceptionally rigorous agency

Michelle Swift

Senior Leadership Team
Medical Affairs
Takeda UK Ltd

 


 
Home | History | Core competencies | Therapy areas | Clients | PHASE II difference | Careers | Case studies | Contact | Sitemap

Version: International | PHASE II UK |© 2008, All rights reserved. PHASE II